Co-infection with coronavirus disease 2019, previously undiagnosed human immunodeficiency virus, Pneumocystis jirovecii pneumonia and cytomegalovirus pneumonitis, with possible immune reconstitution inflammatory syndrome

•Co-infection with COVID-19 and HIV should be considered in people with risk factors.•People with AIDS can have both COVID-19 and opportunistic infections.•People with AIDS and COVID-19 may be at risk for immune reconstitution syndrome.•Further study of COVID-19 in people with AIDS is needed. Case r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:IDCases 2021-01, Vol.24, p.e01153, Article e01153
Hauptverfasser: Merchant, Elisabeth A., Flint, Kristen, Barouch, Dan H., Blair, Barbra M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Co-infection with COVID-19 and HIV should be considered in people with risk factors.•People with AIDS can have both COVID-19 and opportunistic infections.•People with AIDS and COVID-19 may be at risk for immune reconstitution syndrome.•Further study of COVID-19 in people with AIDS is needed. Case reports, case series and cohort studies have been published describing the clinical course and outcomes of people living with human immunodeficiency virus (PLWH) who contract coronavirus disease 2019 (COVID-19) pneumonia. However, the majority of the published work focuses on patients with well-controlled human immunodeficiency virus (HIV) on antiretroviral therapy (ART). We present a case of a new diagnosis of HIV with Acquired Immune Deficiency Syndrome (AIDS) made simultaneously to diagnosis of COVID-19, with co-infection with pneumocystis jirovecii pneumonia (PJP) and possible cytomegalovirus (CMV) pneumonitis. The patient decompensated following initiation of ART, suggestive of possible immune reconstitution inflammatory syndrome (IRIS). This case illustrates the importance of maintaining a high suspicion for HIV/AIDS in patients with risk factors. Additionally, this case raises the possibility that IRIS may develop in the setting of ART initiation in patients with COVID-19.
ISSN:2214-2509
2214-2509
DOI:10.1016/j.idcr.2021.e01153